116 related articles for article (PubMed ID: 37192548)
1. Serum pro-surfactant protein B is correlated with clinical properties in osteosarcoma patients.
Feng S; Fu D; Zhang Y; Zhang L; Ji Y; Li H; A L
Biochem Cell Biol; 2023 Oct; 101(5):456-463. PubMed ID: 37192548
[TBL] [Abstract][Full Text] [Related]
2. Gene polymorphisms of SFTPB rs7316, rs9752 and PAOX rs1046175 affect the diagnostic value of plasma Pro-SFTPB and DAS in Chinese Han non-small-cell lung cancer patients.
Wang K; Huang Q; Zhao G; Yang J; Yang K; Huang Y
J Cell Biochem; 2019 Sep; 120(9):14804-14812. PubMed ID: 31016788
[TBL] [Abstract][Full Text] [Related]
3. Identification of serum miR-124 as a biomarker for diagnosis and prognosis in osteosarcoma.
Cong C; Wang W; Tian J; Gao T; Zheng W; Zhou C
Cancer Biomark; 2018 Feb; 21(2):449-454. PubMed ID: 29125481
[TBL] [Abstract][Full Text] [Related]
4. Circulating pro-surfactant protein B as a risk biomarker for lung cancer.
Taguchi A; Hanash S; Rundle A; McKeague IW; Tang D; Darakjy S; Gaziano JM; Sesso HD; Perera F
Cancer Epidemiol Biomarkers Prev; 2013 Oct; 22(10):1756-61. PubMed ID: 23897585
[TBL] [Abstract][Full Text] [Related]
5. High serum alkaline phosphatase cooperating with MMP-9 predicts metastasis and poor prognosis in patients with primary osteosarcoma in Southern China.
Han J; Yong B; Luo C; Tan P; Peng T; Shen J
World J Surg Oncol; 2012 Feb; 10():37. PubMed ID: 22333159
[TBL] [Abstract][Full Text] [Related]
6. XB130 expression in human osteosarcoma: a clinical and experimental study.
Wang X; Wang R; Liu Z; Hao F; Huang H; Guo W
Int J Clin Exp Pathol; 2015; 8(3):2565-73. PubMed ID: 26045762
[TBL] [Abstract][Full Text] [Related]
7. Serum microRNA-221 functions as a potential diagnostic and prognostic marker for patients with osteosarcoma.
Yang Z; Zhang Y; Zhang X; Zhang M; Liu H; Zhang S; Qi B; Sun X
Biomed Pharmacother; 2015 Oct; 75():153-8. PubMed ID: 26422796
[TBL] [Abstract][Full Text] [Related]
8. Diacetylspermine Is a Novel Prediagnostic Serum Biomarker for Non-Small-Cell Lung Cancer and Has Additive Performance With Pro-Surfactant Protein B.
Wikoff WR; Hanash S; DeFelice B; Miyamoto S; Barnett M; Zhao Y; Goodman G; Feng Z; Gandara D; Fiehn O; Taguchi A
J Clin Oncol; 2015 Nov; 33(33):3880-6. PubMed ID: 26282655
[TBL] [Abstract][Full Text] [Related]
9. Pro-surfactant protein B as a biomarker for lung cancer prediction.
Sin DD; Tammemagi CM; Lam S; Barnett MJ; Duan X; Tam A; Auman H; Feng Z; Goodman GE; Hanash S; Taguchi A
J Clin Oncol; 2013 Dec; 31(36):4536-43. PubMed ID: 24248694
[TBL] [Abstract][Full Text] [Related]
10. Neuropilin-1 is overexpressed in osteosarcoma and contributes to tumor progression and poor prognosis.
Zhu H; Cai H; Tang M; Tang J
Clin Transl Oncol; 2014 Aug; 16(8):732-8. PubMed ID: 24338507
[TBL] [Abstract][Full Text] [Related]
11. Expression of Leptin and Sirtuin-1 is associated with poor prognosis in patients with osteosarcoma.
Feng H; Guo P; Wang J; Xu J; Xie C; Gao F
Pathol Res Pract; 2016 Apr; 212(4):319-24. PubMed ID: 26936024
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of relaxin-2 and S100A4 expression in osteosarcoma.
Huang H; Zheng HY; Liu ZL; Zhang L
Eur Rev Med Pharmacol Sci; 2014 Oct; 18(19):2828-34. PubMed ID: 25339476
[TBL] [Abstract][Full Text] [Related]
13. High expression of long non-coding RNA LOC730101 correlates with distant metastasis and exhibits a poor prognosis in patients with osteosarcoma.
Li SW; Hu KZ; Chen SC; Liu SL; Wang YH
Eur Rev Med Pharmacol Sci; 2018 Jul; 22(13):4115-4120. PubMed ID: 30024599
[TBL] [Abstract][Full Text] [Related]
14. High expression levels of Cyr61 and VEGF are associated with poor prognosis in osteosarcoma.
Liu Y; Zhang F; Zhang Z; Wang D; Cui B; Zeng F; Huang L; Zhang Q; Sun Q
Pathol Res Pract; 2017 Aug; 213(8):895-899. PubMed ID: 28647210
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of pre-treatment Naples prognostic score (NPS) in patients with osteosarcoma.
Yang Q; Chen T; Yao Z; Zhang X
World J Surg Oncol; 2020 Jan; 18(1):24. PubMed ID: 32000789
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic and prognostic implications of serum miR-101 in osteosarcoma.
Yao ZS; Li C; Liang D; Jiang XB; Tang JJ; Ye LQ; Yuan K; Ren H; Yang ZD; Jin DX; Zhang SC; Ding JY; Tang YC; Xu JX; Chen K; Xie WX; Guo DQ; Cui JC
Cancer Biomark; 2018; 22(1):127-133. PubMed ID: 29630525
[TBL] [Abstract][Full Text] [Related]
17. Actin-like protein 6A is a novel prognostic indicator promoting invasion and metastasis in osteosarcoma.
Sun W; Wang W; Lei J; Li H; Wu Y
Oncol Rep; 2017 Apr; 37(4):2405-2417. PubMed ID: 28260090
[TBL] [Abstract][Full Text] [Related]
18. Decreased expression of long non-coding RNA MEG3 acts as a potential predictor biomarker in progression and poor prognosis of osteosarcoma.
Tian ZZ; Guo XJ; Zhao YM; Fang Y
Int J Clin Exp Pathol; 2015; 8(11):15138-42. PubMed ID: 26823857
[TBL] [Abstract][Full Text] [Related]
19. Increased expression of CD24 is associated with tumor progression and prognosis in patients suffering osteosarcoma.
Tang J; Cai H; Lin L; Xie P; Zhong W; Tang M
Clin Transl Oncol; 2013 Jul; 15(7):541-7. PubMed ID: 23143956
[TBL] [Abstract][Full Text] [Related]
20. Down-regulation of microRNA152 is associated with the diagnosis and prognosis of patients with osteosarcoma.
Wang NG; Wang DC; Tan BY; Wang F; Yuan ZN
Int J Clin Exp Pathol; 2015; 8(8):9314-9. PubMed ID: 26464682
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]